Literature DB >> 2564215

Dipeptidyl peptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV.

E Schön1, H U Demuth, E Eichmann, H J Horst, I J Körner, J Kopp, T Mattern, K Neubert, F Noll, A J Ulmer.   

Abstract

Specific inhibitors of the membrane-bound dipeptidyl peptidase IV (DP IV) and polyclonal antibodies against this enzyme were used to investigate the relationships between DP IV activity and the production and action of T cell-derived lymphokines. Production of interleukin 2 (IL-2) and gamma interferon by mitogen plus phorbol ester-stimulated mononuclear cells from human blood was found to be reduced in the presence of N-Ala-Pro-O-(nitrobenzoyl-)-hydroxylamine, epsilon-(4'-nitro) benzoxycarbonyl-Lys-Pro, and anti-(DP IV) immunoglobulin in a dose-dependent manner. Moreover, the proliferative response of mitogen-stimulated mononuclear cells to IL-2 is impaired in the presence of DP IV inhibitors. Therefore it is suggested that the membrane peptidase DP IV is involved in the induction and activation of cytokines controlling lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564215     DOI: 10.1111/j.1365-3083.1989.tb01108.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  14 in total

Review 1.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

2.  Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.

Authors:  D Reinhold; U Bank; F Bühling; U Lendeckel; J Faust; K Neubert; S Ansorge
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines.

Authors:  D Brömme; A Schierhorn; H Kirschke; B Wiederanders; A Barth; S Fittkau; H U Demuth
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

4.  Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.

Authors:  G R Flentke; E Munoz; B T Huber; A G Plaut; C A Kettner; W W Bachovchin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

5.  Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components.

Authors:  E Nemoto; S Sugawara; H Takada; S Shoji; H Horiuch
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.

Authors:  Marcus Lettau; Michelle Dietz; Sarah Vollmers; Fred Armbrust; Christian Peters; Thi Mai Dang; Guranda Chitadze; Dieter Kabelitz; Ottmar Janssen
Journal:  Cell Mol Life Sci       Date:  2019-07-12       Impact factor: 9.261

7.  The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Authors:  T Tanaka; J Kameoka; A Yaron; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

8.  Involvement of dipeptidyl peptidase IV in an in vivo immune response.

Authors:  T Kubota; G R Flentke; W W Bachovchin; B D Stollar
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 9.  The evolution of proteinase substrates with special reference to dipeptidylpeptidase IV.

Authors:  R E Smith; C J Reynolds; E A Elder
Journal:  Histochem J       Date:  1992-09

10.  Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells.

Authors:  V Stefanovic; N Ardaillou; P Vlahovic; S Placier; P Ronco; R Ardaillou
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.